Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
This is a national observational retrospective multi-site chart review study of patients with advanced, recurrent or metastatic endometrial carcinoma.
Oncology|Endometrial Cancer|Advanced Cancer|Recurrent Cancer|Metastatic Cancer
DRUG: Chemotherapy
Clinical, biological and treatment characteristics, Description of the data, up to 3 years
Progession Free Survival real world (rwPFS), From the date of initiation of the treatment in the corresponding line to the date of progression or death, through study completion, an average of 1 year|Overall Survival (OS), From the date of initiation of the treatment in the corresponding line to the date of death, through study completion, an average of 1 year
This is a national observational retrospective multi-site chart review study of patients with advanced, recurrent or metastatic endometrial carcinoma.